Technologies de la santé et prise de décision

Les technologies de la santé offrent d’immenses perspectives : elles ont le pouvoir de modifier notre compréhension de la maladie, de transformer les prestations de services de santé, et d’améliorer les résultats dans ce domaine. Mais le recours à ces technologies a un prix. Les décisions qui gouvernent leur achat et leur utilisation doivent être fondées sur des observations solides permettant d’apprécier leur impact sur les soins et

Définition statistique de la biotechnologie (mise à jour en 2005)

Définition statistique de la biotechnologie

Workshop on Pharmacogenetics: The Intersections between Innovation, Regulation and Health Delivery,

This workshop brought together a wide range of stakeholders, including officials of regulatory agencies, representatives of relevant regional or international organizations, researchers, patients’ organizations and representative from industry.

Related Documents

• Pharmacogenetics

Analysing European and International Patent Citations: A Set of EPO Patent Database Building Blocks (STI Working Paper 2005/9)

This paper presents a preliminary set of European and international citation data tables designed to enable researchers to become familiar with the subject and undertake a range of analyses.

OECD Scoreboard 2005: Briefing note for the United States

This note summarises recent developments in science, technology and innovation in the United States.

Related Documents

• to be changed

OECD Scoreboard 2005: Briefing note for the United Kingdom

This note summarises recent developments in science, technology and innovation in the United Kingdom.

Related Documents

• to be changed
• Scoreboard 2005 Executive Summary English

OECD Scoreboard 2005: Briefing note for France

This note summarises recent developments in science, technology and innovation in France.

Related Documents

• to be changed

OECD Scoreboard 2005: Briefing note for Germany

This note summarises recent developments in science, technology and innovation in Germany.

Related Documents

• to be changed

OECD Scoreboard 2005: Briefing note for Japan

This note summarises recent developments in science, technology and innovation in Japan.

Related Documents

• to be changed
• OECD Scoreboard 2005: Executive Summary in Japanese

Workshop on the Safety of Manufactured Nanomaterials

The main objective of the Workshop on the Safety of Manufactured Nanomaterials was to determine the “state-of–the–art” for the safety assessment of manufactured nanomaterials with a particular focus on identifying future needs for risk assessment within a regulatory context.